Why is Inovio Board investing in the Co. even as shares crash? It's a tell to a card player- A strong future movement is in the cards?

The Board is among the Largest Shareholders- ask why would they gamble on dilutive share sales to bolster capital in a recession in US? Answer: They're sure we're approaching daylight-they have experts, Funds for 3107-3100-5412-Factor VIII rollout: will pay off, they know how it will go. INO's Board are experts in their fields, why would they gamble their life savings on a nearly bankrupt company? Are they dummies or something?Think again- Their long tenures in Ino's scientifically demonstrated DNA enhanced treatments, many of if not all of which have been proven to enhance their target antigens- we always lacked money, but approvals among FDA staff who are money-ball players on low government salaries, always "follow the money"- once we get this last final share sale, July 3100 news, September progress of 3107 BLA, 5412 evidence, and D-PROT, partnerships- we will have BP Biotech world courting us. Ask why BP spends-2 billion for a promising company like nothing?

Because it's what it takes to launch 1 pharma drug-all BPs face lost revenue due to Medicare price controls & patent expirations. So any of those can and will pay for a high probable, quality treatment, ready for approval. The Board can't announce 'news' but they are in the same boat as me& shareholders. I opened my ears- I won't sell until at least Oct. 31, 2026. Remember March 2024 $14-15 pop? Smart Money tells you, History repeats, Buy-Hold. And $14.74 is coming in Winter 2026- because even if we have 100 million shares in Float = $20 per share on a $2 billion buyout. Understand that our cards are still in play, and we are not going bankrupt. Long 350k. Get ready to buy the fire sale prices- my love to shorts! The Board's bull capital-raise investment is a tell to a card player. Who dilutes their #1 holding if a dying Co. - their actions are contrary to the price moves- tell me why that is?